SLBT
SL Science Holding Limited Ordinary Shares
NASDAQ · Healthcare · Biotechnology · US
$2.88
−8.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 707.12x
- Price / sales
- 735.00x
- Price / cash flow
- -845.63x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 734.53x
- EV / EBITDA
- -431.10x
- EV / EBIT
- -420.57x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025